SeraCare Life Sciences (SRLS) Tops Q1 EPS by 1c
Tweet
Share
E-mailGet Alerts SRLS Hot Sheet
Join SI Premium – FREE
SeraCare Life Sciences, Inc. (Nasdaq: SRLS) reported Q1 EPS of $0.07, $0.01 better than the analyst estimate of $0.06. Revenue for the quarter came in at $11 million versus the consensus estimate of $11.21 million.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Blackhawk Network (HAWK) Reports Q2 Loss of $0.07; Offers Guidance
- Calidi Biotherapeutics (CLDI) Reports Q2 Loss of $2.94
- Eikon Therapeutics, Inc. (EIKN) Misses Q2 EPS by 163c
Create E-mail Alert Related Categories
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
